Coleman Mark

CIK 00016583791 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001658379

Recent Transactions

50 trades

Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-02-26$161.11/sh−25,000→ 47,140 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2026-02-23−6,250→ 7,721 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-02-23$4.95/sh+6,250→ 72,140 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2026-02-20−12,485→ 13,971 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-02-20$4.95/sh+12,485→ 65,890 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-02-10$8.02/sh+5,193→ 53,405 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2026-02-10−5,193→ 0 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-08$127.30/sh+287→ 47,724 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-08$127.20/sh+800→ 47,437 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-08$127.40/sh+488→ 48,212 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2025-06-06+1,429→ 1,429 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-06-06+3,166→ 3,166 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-05-28$103.43/sh−3,750→ 46,637 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-05-27$105.47/sh−3,750→ 50,387 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-05-20$107.49/sh−3,000→ 54,137 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-01-03$9.00/sh+9,127→ 57,137 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-01-03−9,127→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-11-19$5.94/sh+33,410→ 48,010 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-11-19−33,410→ 0 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-06-07+5,799→ 5,799 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-05-29$75.14/sh−5,248→ 14,600 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-05-28$75.21/sh−5,249→ 19,848 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2023-09-15−11,016→ 0 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2023-09-15$75.19/sh−11,016→ 25,097 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2023-09-15$3.67/sh+11,016→ 36,113 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2023-09-15$75.18/sh−18,572→ 403,856 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2023-06-02+5,681→ 5,681 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2023-03-02+2,870→ 2,870 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2023-01-03−17,501→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2023-01-03$1.30/sh+17,501→ 25,097 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2022-06-03+16,976→ 16,976 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2022-03-15$1.30/sh+3,496→ 7,596 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2022-03-15−3,496→ 17,501 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2022-03-04+2,798→ 2,798 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2021-11-18$35.07/sh+409→ 421,407 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2021-11-18$35.10/sh+1,021→ 422,428 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2021-06-04+7,325→ 7,325 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2021-05-12$58.15/sh+500→ 420,998 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2021-03-05+1,201→ 1,201 total
Gift
Axsome Therapeutics, Inc.$AXSM
Common Stock
2020-08-19−397,998→ 5,700 total
Gift
Axsome Therapeutics, Inc.$AXSM
Common Stock
2020-08-19+397,998→ 397,998 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2020-06-29$78.50/sh+650→ 403,698 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2020-06-05+13,000→ 13,000 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2020-03-17+3,308→ 3,308 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2019-06-26$23.10/sh+15,800→ 668,848 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2019-06-25$23.25/sh+400→ 653,048 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2019-06-07+13,000→ 13,000 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2019-05-13$21.44/sh+4,650→ 652,648 total
Purchase
Axsome Therapeutics, Inc.$AXSM
Common Stock
2019-03-19$12.18/sh+5,100→ 5,100 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2019-03-19+25,652→ 25,652 total

Companies

Axsome Therapeutics, Inc.
Director
$AXSM

Recent Filings

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007

View on SEC.gov